Latest Breaking News On - Oncology development - Page 8 : comparemela.com

Pfizer (PFE) Announces FDA Approval of PADCEV with KEYTRUDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer

Pfizer (PFE) Announces FDA Approval of PADCEV with KEYTRUDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
London
City-of
United-kingdom
Americans
Ahsan-arozullah
Roger-dansey
Thomas-powles
Pfizer-inc
Drug-administration
European-society-for-medical-oncology
Astellas-pharma-inc

Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity at the American Society of Hematology Annual Meeting

Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity at the American Society of Hematology Annual Meeting
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Canada
Cambridge
Cambridgeshire
United-kingdom
United-states
Japan
Treasure-island
Texas
American
Huax-menin
Jatin-shah
Sumitomo-pharma

Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity at the American Society of Hematology Annual Meeting

Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity at the American Society of Hematology Annual Meeting
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Canada
Texas
United-states
Cambridge
Cambridgeshire
United-kingdom
Treasure-island
Japan
American
Huax-menin
Sumitomo-pharma-america
Jatin-shah

Novartis Pharma AG: Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions

Novartis Pharma AG: Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San-antonio
Texas
United-states
Lugano
Ticino
Switzerland
Paris
France-general
France
Chicago
Illinois
Spain